Yahoo
Shanghai - Delayed Quote CNY

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)

34.70 -0.69 (-1.95%)
At close: October 30 at 3:00:01 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
326,055.50
316,076.82
173,532.72
360,253.87
235,957
Cost of Revenue
50,152.85
53,367.63
13,332.46
23,585.55
16,969.77
Gross Profit
275,902.65
262,709.19
160,200.26
336,668.32
218,987.23
Operating Expense
222,409.99
212,750.14
179,961.08
170,189.86
96,577.24
Operating Income
53,492.66
49,959.05
-19,760.82
166,478.47
122,409.99
Net Non Operating Interest Income Expense
13,369.94
13,738.83
17,346.04
26,924.54
18,316.96
Pretax Income
64,424.85
61,149.32
4,817.20
186,900.15
149,561.58
Tax Provision
-5,265.91
-3,406.45
-2,158.08
25,346.23
6,706.68
Net Income Common Stockholders
69,690.76
64,555.77
6,975.28
161,553.92
142,854.91
Basic EPS
0.34
0.32
0.03
1.02
0.76
Diluted EPS
0.34
0.32
0.03
1.02
0.76
Basic Average Shares
204,743.14
201,736.79
232,509.42
158,386.20
187,587.25
Diluted Average Shares
204,743.14
201,736.79
232,509.42
158,386.20
187,587.25
Total Operating Income as Reported
65,148.43
62,264.42
9,540.66
195,453.49
151,587.31
Rent Expense Supplemental
2,812.96
3,398.03
1,931.41
1,650.19
572.90
Total Expenses
272,562.84
266,117.77
193,293.54
193,775.40
113,547.01
Net Income from Continuing & Discontinued Operation
69,690.76
64,555.77
6,975.28
161,553.92
142,854.91
Normalized Income
75,091.22
68,095.27
3,183.89
165,918.65
143,939.30
Interest Income
13,805.72
13,814.26
18,141.72
27,246.52
18,320.08
Interest Expense
427.49
67.15
700.86
269.96
-8.57
Net Interest Income
13,369.94
13,738.83
17,346.04
26,924.54
18,316.96
EBIT
64,852.35
61,216.47
5,518.06
187,170.11
149,553.01
EBITDA
64,852.35
73,202.64
16,681.51
195,052.84
155,980.16
Reconciled Cost of Revenue
50,152.85
53,367.63
13,332.46
23,585.55
16,969.77
Reconciled Depreciation
11,215.05
11,986.17
11,163.45
7,882.73
6,427.15
Net Income from Continuing Operation Net Minority Interest
69,690.76
64,555.77
6,975.28
161,553.92
142,854.91
Total Unusual Items Excluding Goodwill
-7,200.62
-4,719.33
5,055.19
-5,049.51
-1,135.30
Total Unusual Items
-7,200.62
-4,719.33
5,055.19
-5,049.51
-1,135.30
Normalized EBITDA
72,052.97
77,921.97
11,626.33
200,102.35
157,115.46
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,800.15
-1,179.83
1,263.80
-684.78
-50.91
12/31/2022 - 9/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: